Esperante Ventures
Overview
Esperante Ventures is a corporate venture capital firm affiliated with a global life science group, boasting leadership with deep operational expertise in the development, manufacturing, and global marketing of prescription pharmaceuticals and in vitro clinical diagnostic tests . Since its establishment in 2004, Esperante has strategically invested in pharmaceutical and diagnostic companies across the US, UK, continental Europe, and Israel . The firm focuses on initial investments of up to EUR 2,000,000 per venture in collaboration with other investors, aiming for exits through sales or liquidity events within a three-year timeframe .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Acousia Therapeutics GmbH | Jan 2024 | VC Round | Co-investor |
| Spiral Therapeutics | Aug 2023 | VC Round | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Esperante Ventures based?
Esperante Ventures is headquartered in Hoofddorp, North Holland, Netherlands.
When was Esperante Ventures founded?
Esperante Ventures was founded in 2004.
How many portfolio companies does Esperante Ventures have?
Esperante Ventures has 3 portfolio companies in Caplight's dataset.
What are some companies in Esperante Ventures's portfolio?
Portfolio companies visible on Caplight include Acousia Therapeutics GmbH, Spiral Therapeutics.
What was Esperante Ventures's most recent investment shown here?
Esperante Ventures's most recent investment in this portfolio sample was in Acousia Therapeutics GmbH in 2024.
What sectors does Esperante Ventures focus on?
Esperante Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Esperante Ventures focus on?
Stage focus information for Esperante Ventures is not publicly available.
What is Esperante Ventures's AUM?
Esperante Ventures's assets under management are estimated between $0.0 and $50.0M.